Herein, we have designed and prepared resveratrol (RV)-loaded HSA nanoparticles conjugating RGD (arginine–glycine–aspartate) via a polyethylene glycol (PEG) “bridge” (HRP–RGD NPs) for highly effective targeted pancreatic tumor therapy. The gene discussed is ALB; the disease is pancreatic neoplasm.